Literature DB >> 3754523

[Ogilvie's syndrome: results of endoscopic exsufflation in a series of 29 cases].

A Lavignolle, P Jutel, J Bonhomme, D Cloarec, P Cerbelaud, P A Lehur, J P Galmiche, L Le Bodic.   

Abstract

The aim of this study was to assess the value of endoscopic decompression of the colon in a series of 29 patients affected with Ogilvie's syndrome. During the first period (1980-1982), 14 patients were treated by colonoscopic decompression alone. During the second period (1982-1985), 15 endoscopic decompressions were systematically completed by intubation of the colon. The tube was removed after 2 to 13 days. Whatever the procedure, endoscopic decompression was successfully achieved in all cases. The death rate (8/29) and number of cecostomies (2/29) were similar in the two groups of patients. Only one death was directly related to Ogilvie's syndrome itself, whereas 7 patients died from other severe underlying diseases. However, colonic dilatation recurred in 6 patients in the first group and in one patient in the second group (p less than 0.05). No complications due to the endoscopic procedures occurred in this series. It may be concluded that endoscopic treatment of Ogilvie's syndrome is a safe and effective procedure. Our results also suggest that colonoscopic intubation should be used prophylactically in order to avoid recurrences, frequently observed after simple endoscopic decompression.

Entities:  

Mesh:

Year:  1986        PMID: 3754523

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

Review 1.  Acute colonic pseudo-obstruction (Ogilvie's syndrome). Presentation of 14 of our own cases and analysis of 1027 cases reported in the literature.

Authors:  M Wegener; G Börsch
Journal:  Surg Endosc       Date:  1987       Impact factor: 4.584

2.  [The Ogilvie syndrome in a severely burned patient].

Authors:  S Siah; H Seddik; K Ababou; H Ihrai; N Drissi Kamili
Journal:  Ann Burns Fire Disasters       Date:  2011-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.